Early research (Phase 1)Active Not RecruitingNCT05990751
What this trial is testing
Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma
Who this might be right for
Neuroblastoma
University College, London 12
Showing 20 of 0 results